How useful is corticosteroid treatment in cochlear disorders?

Oto-Rhino-Laryngologia Nova

Volumn 9, Issue 5, 1999, Pages 203-216

  Lamm, Kerstin ^a   Arnold, Wolfgang ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

Auditory evoked potentials; Cochlea; Cochlear blood flow; Cochlear hypoxia; Corticosteroids; Glucocorticoids; Meniere's disease; Mineralocorticoids; Noise induced hearing loss; Perilymph pO2; Sensorineural hearing loss; Sudden deafness; Tinnitus

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID; MINERALOCORTICOID;

ARTICLE; COCHLEA BLOOD FLOW; COCHLEA FENESTRA; CORTICOSTEROID THERAPY; EVOKED AUDITORY RESPONSE; HEARING LOSS; INNER EAR DISEASE; MENIERE DISEASE; NOISE; PERCEPTION DEAFNESS; PERILYMPH; SUDDEN DEAFNESS; TINNITUS;

EID: 0033512032     PISSN: 10148221     EISSN: None     Source Type: Journal    
DOI: 10.1159/000027909     Document Type: Article

References (198)

1. Haynes RC Jr: Adrenocorticotrophic hormone: Adrenocortical steroids and their synthetic analogs: Inhibitors of the synthesis and actions of adrenocortical hormones; in Goodman Gilman A, Rall TW, Nies AS, Taylor P (eds): Goodman and Gilman's Pharmacological Basis of Therapeutics, ed. 8. New York, Pergamon Press, 1990, pp 1431-1462.
2. Schimmer BP, Parker KL: Adrenocorticotrophic hormone: Adrenocortical steroids and their synthetic analogs: Inhibitors of the synthesis and actions of adrenocortical hormones; in Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A (eds): Goodman and Gilman's Pharmacological Basis of Therapeutics, ed 9. New York, McGraw-Hill, 1996, pp 1459-1485.
3. Insel PA: Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout; in Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A (eds): Goodman and Gilman's Pharmacological Basis of Therapeutics, ed 9. New York, McGraw-Hill, 1996, pp 617-657.
4. Korompilias AV, Chcn LE, Seaber AV, Urbaniak JR: Actions of glucocorticosteroids on ischemic-reperfused muscle and cutaneous tissue. Microsurgery 1996;17:495-502.
5. Bamberger CM, Schulte HM, Chrousos GP: Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 1996;17:245-261.
6. Barnes PJ: Anti-inflammatory actions of glucocorticoids: Molecular mechanisms. Clin Sci (Colch) 1998;94:557-572.
7. Benediktsson R, Edwards CR:11-Beta-hydroxysteroid dehydrogenases: Tissue-specific dictators of glucocorticoid action. Essays Biochem 1996;31:23-36.
8. Bonvalet JP: Regulation of sodium transport by steroid hormones. Kidney Int Suppl 1998; 65:S49-S56.
9. Brattsand R, Linden M: Cytokine modulation by glucocorticoids: Mechanisms and actions in cellular studies. Aliment Pharmacol Ther 1996; 10(suppl2):81-90.
10. Brem AS, Morris DJ: Interactions between glucocorticoids and mineralocorticoids in the regulation of renal electrolyte transport. Mol Cell Endocrinol 1993;97:C1-C5.
11. Buttgereit F, Dimmeler S, Neugebauer E, Burmester GR: Wirkungsmechanismen der hochdosierten Glucocorticoidtherapie. Dtsch Med Wochenschr 1996;121:248-252.
12. Chapman KE, Kotelevtsev YV, Jamieson PM, Williams LJ, Mullins JJ, Seckl JR: Tissue-specific modulation of glucocorticoid action by the 11-beta-hydroxysteroid dehydrogenases. Biochem Soc Trans 1997;25:583-587.
13. Christ M, Haseroth K, Falkcnstein E, Wehling M: Nongenomic steroid actions: Fact or fantasy? Vitam Horm 1999;57:325-373.
14. Damm K, Rupprecht R, Holsboer F: The binary corticoid response: Transcriptional regulation by mineralo- and glucocorticoid receptors. Ann NY Acad Sci 1994;746:79-87.
15. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M: Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998;19:269-301.
16. De Nicola AF, Ferrini M, Gonzales SL, Gonzales Deniselle MC, Grillo CA, Piroli G, Saravia F, de Kloet ER: Regulation of gene expression by corticoid hormones in the brain and spinal cord. J Steroid Biochem Mol Biol 1998; 65:253-272.
17. Didonato JA, Saatcioglu F, Karin M: Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids. Am J Respir Crit Care Med 1996;154: S11-S15.
18. Diederich S, Quinklcr M, Hanke B, Bahr V, Oelkers W: 11-Beta-Hydroxysteroid-Dehydrogenasen: Schlüsselenzyme der Mineralcorticoid- und Glucocorticoid-Wirkung. Dtsch Med Wochenschr 1999;124:51-55.
19. Farman N: Molecular and cellular determinants of mineralocorticoid selectivity. Curr Opin Nephrol Hypertens 1999;8:45-51.
20. Frey FJ, Escher G, Frey BM: Pharmacology of 11-beta-hydroxysteroid dehydrogenase. Steroids 1994;59:74-79.
21. Fuchs E, Flugge G: Stress, glucocorticoids and structural plasticity of the hippocampus. Neurosci Biobehav Rev 1998;23:295-300.
22. Funder JW: Mineralocorticoid receptors and glucocorticoid receptors. Clin Endocrinol (Oxf) 1996;45:651-656.
23. Funder JW: Glucocorticoid and mineralocorticoid receptors: Biology and clinical relevance. Annu Rev Med 1997;48:231-240.
24. Funder JW: Aldosterone action: Fact, failure and the future. Clin Exp Pharmacol Physiol Suppl 1998;25:S47-S50.
25. Hall ED: Steroids and neuronal destruction or stabilization. Ciba Found Symp 1990;153: 206-214.
26. Hall ED: Neuroprotective actions of glucocorticoid and nonglucocorticoid steroids in acute neuronal injury. Cell Mol Neurobiol 1993;13: 415-432.
27. Haller J, Halasz J, Makara GB, Kruk MR: Acute effects of glucocorticoids: Behavioral and pharmacological perspectives. Neurosci Biobehav Rev 1998;23:337-344.
28. Herbert J: Fortnighly review. Stress, the brain, and mental illness. BMJ 1997;315:530-535.
29. Herbert J: Neurosteroids, brain damage, and mental illness. Exp Gerontol 1998;33:713-727.
30. Hinz B, Hirschelmann RR: Neuere Erkenntnisse zur endogenen Regulation der Glucocorticoide. Pharmazie 1997;52:655-669.
31. Holsboer F, Grasser A, Friess E, Wiedemann K: Steroid effects on central neurons and implications for psychiatric and neurological disorders. Ann NY Acad Sci 1994;746:345-359.
32. Joels M: Steroid hormones and excitability in the mammalian brain. Front Neuroendocrinol 1997;18:2-48.
33. Joels M, Vreugdenhil E: Corticosteroids in the brain. Cellular and molecular actions. Mol Neurobiol 1998;17:87-108.
34. Kaiser H, Kley HK: Cortisontherapie. Corticoide in Klinik und Praxis, ed 10. Stuttgart, Thieme, 1997.
35. Lopez-Figueroa MO, Day HE, Akil H, Watson SJ: Nitric oxide in the stress axis. Histol Histopathol 1998;13:1243-1252.
36. Lupien SJ, McEwen BS: The acute effects of corticosteroids on cognition: Integration of animal and human model studies. Brain Res Brain Res Rev 1997;24:1-27.
37. Marx J: How the glucocorticoids suppress immunity. Science 1995;270:232-233.
38. McAllister-Williams RH, Ferrier IN, Young AH: Mood and neuropsychological function in depression: The role of corticosteroids and serotonin. Psychol Med 1998;28:573-584.
39. McEwen BS: The brain is an important target of adrenal steroid actions: A comparison of synthetic and natural steroids. Ann NY Acad Sci 1997;823:201-213.
40. McEwen BS, Biron CA, Brunson KW, Bulloch K, Chambers WH, Dhabhar FS, Goldfarb RH, Kitson RP, Miller AH, Spencer RL, Weiss JM: The role of adrenocorticoids as modulators of immune function in health and disease: Neuronal, endocrine and immune interactions. Brain Res Brain Res Rev 1997;23:79-133.
41. McMahon M, Gerich J, Rizza R: Effects of glucocorticoids on carbohydrate metabolism. Diabet Metab Rev 1988;4:17-30.
42. Meijer OC, de Kloet ER: Corticosterone and serotonergic neurotransmission in the hippocampus: Functional implications of central corticosteroid receptor diversity. Crit Rev Neurobiol 1998;12:1-20.
43. Moore FL, Orchinik M, Lowry C: Functional studies of corticosterone receptors in neuronal membranes. Receptor 1995;5:21-28.
44. Morris DJ: The role of steroid metabolism in protective and specificity conferring mechanisms of mineralocorticoid action. Vitam Horm 1995;50:461-485.
45. Naray-Fejes-Toth A, Colomowala IK, Fejes-Toth G: The role of 11-beta-hydroxysteroid dehydrogenase in steroid hormone specificity. J Steroid Biochem Mol Biol 1998;65:311-316.
46. Oitzl MS, van Haarst AD, de Kloet ER: Behavioral and neuroendocrine responses controlled by the concerted action of central mineralocorticoid (MRS) and glucocorticoid receptors (GRC). Psychoneuroendocrinology 1997; 22(suppl 1):S87-S93.
47. Oppermann UC, Persson B, Jornvall H: Function, gene organization and protein structures of 11-beta-hydoxysteroid dehydrogenase isoforms. Eur J Biochem 1997;249:355-360.
48. Orchinik M, Moore FL, Rose JD: Mechanistic and functional studies of rapid corticosteroid actions. Ann NY Acad Sci 1994;746:101-112.
49. Porsti I, Paakkari I: Nitric oxide-based possibilities for pharmacotherapy. Ann Med 1995; 27:407-420.
50. Rafestin-Oblin ME, Couette B: Récepteurs de l'aldostérone: données récentes sur la transduction du signal hormonal. Thérapie 1998;53: 227-235.
51. Reagan LP, McEwen BS: Controversies surrounding glucocorticoid-mediated cell death in the hippocampus. J Chem Neuroanat 1997;13: 149-167.
52. Sapolsky RM: Stress, glucocorticoids, and damage to the nervous system: The current state of confusion. Stress 1996;1:1-19.
53. Sapolsky RM: McEwen-induced modulation of endocrine history: A partial review. Stress 1997;2:1-12.
54. Schedlowski M, Tewes U: Psychoneuroimmunologie. Heidelberg, Spektrum, 1996.
55. Schmidt BM, Christ M, Falkenstein E, Wehling M: Nongenomic steroid actions: Completing the puzzle. Aldosterone as an example. Exp Clin Endocrinol Diabet 1998;106:441-445.
56. Schobitz B, Reul JM, Holsboer F: The role of the hypothalamic-pituitary-adrenocortical system during inflammatory conditions. Crit Rev Neurobiol 1994;8:263-291.
57. Seckl JR: 11-Beta-hydroxysteroid dehydrogenase in the brain: A novel regulator of glucocorticoid action? Front Neuroendocrinol 1997;18: 49-99.
58. Szabo C: Regulation of the expression of the inducible isoform of nitric oxide synthase by glucocorticoids. Ann NY Acad Sci 1998;851: 336-341.
59. Trapp T, Holsboer F: Heterodimerization between mineralocorticoid and glucocorticoid receptors increase the functional diversity of corticosteroid action. Trends Pharmacol Sci 1996; 17:145-149.
60. Ulick S: Cortisol as mineralocorticoid. J Clin Endocrinol Metab 1996;81:1307-1308.
61. Ullian ME: The role of corticosteroids in the regulation of vascular tone. Cardiovasc Res 1999;41:55-64.
62. Van Uum SH, Hermus AR, Smits P, Thien T, Lender JW: The role of 11-beta-hydroxysteroid dehydrogenase in the pathogenesis of hypertension. Cardiovasc Res 1998;38:16-24.
63. Wehling M: Novel aldosterone receptors: Specificity-conferring mechanism at the level of the cell membrane. Steroids 1994;59:160-163.
64. Wehling M: Looking beyond the dogma of genomic steroid action: Insights and facts of the 1990s. J Mol Med 1995;73:439-447.
65. Wehling M: Specific, nongenomic actions of steroid hormones. Annu Rev Physiol 1997;59: 365-393.
66. Wiegers GJ, Reul JM: Induction of cytokine receptors by glucocorticoids: Functional and pathological significance. Trends Pharmacol Sci 1998;19:317-321.
67. Wilckens T: Glucocorticoids and immune function: Physiological relevance and pathogenic potential of hormonal dysfunction. Trends Pharmacol Sci 1995;16:193-197.
68. Wilckens T, De Rijk R: Glucocorticoids and immune functions: Unknown dimensions and new frontiers. Immunol Today 1997;18:418-424.
69. Alexiou C, Kau RJ, Luppa P, Arnold W: Allergic reactions after systemic administration of glucocorticosteroid therapy. Arch Otolaryngol Head Neck Surg 1998;124:1260-1264.
70. Rarey KE, Luttge WG: Presence of type I and typcII/IB receptors for adrenocorticosteroid hormones in the inner ear. Hear Res 1989;41: 217-222.
71. Rarey KE, Curtis LM: Receptors for glucocorticoids in the human inner ear. Otolaryngol Head Neck Surg 1996;115:38-51.
72. Rarey KE, Curtis LM, ten Cate WJ: Tissue specific levels of glucocorticoid receptors within the rat inner ear. Hear Res 1993;64:205-210.
73. ten Cate WJF, Curtis LM, Rarey KE: Immunochemical detection of glucocorticoid receptors within rat cochlear and vestibular tissues. Hear Res 1992;60:199-204.
74. ten Cate WJ, Curtis LM, Small GM, Rarey KE: Localization of glucocorticoid receptors and glucocorticoid receptor mRNAs in the rat cochlea. Laryngoscope 1993;103:865-871.
75. Pitovski DZ, Drescher MJ, Drescher DG: Glucocorticoid receptors in the mammalian inner ear: RU 28362 binding sites. Hear Res 1994; 77:216-220.
76. Zuo J, Curtis L, Yao X: Glucocorticoid receptor expression in the postnatal rat cochlea. Hear Res 1995;87:220-227.
77. Erichsen S, Bagger-Sjöbäck D, Curtis L, Zuo J, Rarey KE, Hultcrantz M: Appearance of glucocorticoid receptors in the inner ear of the mouse during development. Acta Otolaryngol (Stockh) 1996;116:721-725.
78. Curtis LM, Rarey KE: Effect of stress on cochlear glucocorticoid protein. II. Restraint. Hear Res 1995;92:120-125.
79. Rarey KE, Gerhardt KJ, Curtis LM, ten Cate WJ: Effect of stress on cochlear glucocorticoid protein: Acoustic stress. Hear Res 1995;82: 135-138.
80. Yao X, Buhi WC, Alvarez IM, Curtis LM, Rarcy KE: De novo synthesis of glucocorticoid hormone regulated inner ear proteins in rats. Hear Res 1995;86:183-188.
81. Furuta H, Mori N, Sato C, Hoshikawa H, Sakai S, Iwakura S, Doi K: Mineralocorticoid type I receptor in the rat cochlea: mRNA identification by polymerase chain reaction (PCR) and in situ hybridization. Hear Res 1994;78:175-180.
82. Yao X, Rarey KE: Localization of the mineralocorticoid receptor in rat cochlear tissue. Acta Otolaryngol (Stockh) 1996;116:493-496.
83. Pitovski DZ, Drescher MJ, Drescher DG: High affinity aldosterone binding sites (type I receptors) in the mammalian inner ear. Hear Res 1993;69:10-14.
84. 3H]Aldosterone binding sites (type I receptors) in the lateral wall of the cochlea: Distribution assessment by quantitative autoradiography. Acta Otolaryngol (Stockh) 1995;115:643-647.
85. +)-ATPase sites in the mammalian inner ear. Brain Res 1993; 601:273-278.
86. Lim HH, Miller JM, Dolan D, Raphael Y, Altschuler RA: Noise-induced expression of heat shock proteins in the cochlea; in Axelsson A, Borchgrevink HM, Hamemik RP, Hellström PA, Henderson D, Salvi RJ (eds): Scientific Basis of Noise-Induced Hearing Loss. New York, Thieme Medical Press, 1996, pp 43-49.
87. Neely JG, Thompson AM, Gower DJ: Detection and localization of heat shock protein 70 in the normal guinea pig cochlea. Hear Res 1991;52:403-406.
88. Thompson AM, Neely JG: Induction of heat shock protein in interdental cells by hyperthermia. Otolaryngol Head Neck Surg 1992;107: 769-774.
89. Dechesne CJ, Kim HN, Nowak TS Jr, Wenthold RJ: Expression of heat shock protein, HSP 72, in the guinea pig and rat cochlea after hyperthermia: Immunochemical and in situ hybridization analysis. Hear Res 1992;59:195-204.
90. Akizuki H, Yoshie H, Morita Y, Takahashi K, Hara A, Watanabe T, Uchiyama Y, Kusukari J: Nuclear transition of heat shock protein in guinea pig cochlea after hyperthermia. Hear Res 1995;92:126-130.
91. Gower VC, Thompson AM: Localization of inducible heat shock protein mRNA in the guinea pig cochlea with a nonradioactive in situ hybridization technique. Laryngoscope 1997;107:228-232.
92. Myers MW, Quirk WS, Rizk SS, Miller JM, Altschuler RA: Expression of the major mammalian stress protein in the rat cochlea following transient ischemia. Laryngoscope 1992; 102:981-987.
93. Lim HH, Jenkins OH, Myers MW, Miller JM, Altschuler RA: Detection of HSP 72 synthesis after acoustic overstimulation in rat cochlea. Hear Res 1993;69:146-150.
94. ten Cate WJF, Monder C, Marandici A, Rarey KE: 11-Beta-hydroxysteroid dehydrogenase in the rat inner car. Am J Physiol 1994; 266:E269-E273.
95. ten Cate WJ, Zuo J, Lautermann J, Altenhoff P, Rarey KE: Development of 11-beta-hydroxy-steroid dehydrogenase expression in the rat cochlea. Acta Otolaryngol (Stockh) 1997;117:841-844.
96. Pitovski DZ: Histochemical demonstration of 11-beta-hydroxysteroid dehydrogenase in ampullae of semicircular canals. Acta Otolaryngol (Stockh) 1996;116:737-740.
97. Kuijpers W, van der Vleuten AC, Bonting SL: Cochlear function and sodium and potassium activated adenosine triphosphatase. Science 1967;157:949-950.
98. Kuijpers W: Cation transport and cochlear function. Acta Otolaryngol (Stockh) 1969;67: 200-205.
99. +)-activated ATPase. XXIV. Localization and properties of ATPase in the inner ear of the guinea pig. Biochim Biophys Acta 1969; 173:477-485.
100. +)ATPase systems of the stria vascularis in guinea pig. Acta Otolaryngol (Stockh) 1981;92:433-437.
101. +-ATPase in the mammalian cochlear duct: Significance for cochlear fluid balance. Am J Otolaryngol 1982;3:332-338.
102. +-ATPase in the inner ear and their relevance to Ménière's disease. Am J Otolaryngol 1982;3:353-360.
103. Offner FF, Dallos P, Cheatham MA: Positive endocochlear potential: Mechanism of production by marginal cells of stria vascularis. Hear Res 1987;29:117-124.
104. Yoshihara T, Usami S, Igarashi M, Fermin CD: Ultracytochemical study of ouabain-sensitive, potassium-dependent p-nitrophenylphosphatase activity in the inner ear of the squirrel monkey. Acta Otolaryngol (Stockh) 1987;103:161-169.
105. +-ATPase alpha-subunit in the lateral wall of rat cochlear duct. J Histochem Cytochem 1989; 37:353-363.
106. +-ATPase in gerbil cochlea. J Histochem Cytochem 1989;37:127-134.
107. +)-ATPase alpha-subunit in the tympanic wall of rat cochlear duct. J Histochem Cytochem 1990; 38:225-232.
108. +)-ATPase and carbonic anhydrase in the gerbil's vestibular system. Hear Res 1990;43:205-217.
109. Spicer SS, Schulte BA: Differentiation of inner car fibrocytcs according to their ion transport related activity. Hear Res 1991;56:53-64.
110. Albers FW, van Benthem PP, de Groot JC: De lokalisatie van Na/K ATPase in het binnenoor. Acta Otorhinolaryngol Belg 1992;46: 351-353.
111. Schulte BA, Schmiedt RA: Lateral wall Na,K-ATPase and endocochlear potentials decline with age in quiet-reared gerbils. Hear Res 1992;61:35-46.
112. Curtis LM, ten Cate WJ, Rarey KE: Dynamics of Na,K-ATPase sites in the lateral cochlear wall tissues of the rat. Eur Arch Otorhinolaryngol 1993;250:265-270.
113. Sakagami M, Fukazawa K, Murata J, Matsunaga T: Morphological aspects of transport of potassium ion in the marginal cell. Acta Otolaryngol Suppl (Stockh) 1993;501:63-65.
114. ++)-ATPase, calcium-binding proteins, and carbonic anhydrase in the guinea pig inner ear. Acta Otolaryngol (Stockh) 1994;114:167-176.
115. McGuirt JP, Schulte BA: Distribution of immunoreactive alpha- and beta-subunit isoforms of Na,K-ATPase in the gerbil inner ear. J Histochem Cytochem 1994;42:843-853.
116. Schulte BA, Steel K: Expression of alpha and beta subunit isoforms of Na,K-ATPase in the mouse inner ear and changes with mutations at the Wv or SId loci. Hear Res 1994;78:65-76.
117. ten Cate WJ, Curtis LM, Rarey KE: Na,K-ATPase alpha and beta subunit isoform distribution in the rat cochlear and vestibular tissues. Hear Res 1994;75:151-160.
118. ten Cate WJ, Curtis LM, Rarey KE: Na,K-ATPase subunit isoform expression in the guinea pig endolymphatic sac. ORL J Otorhinolaryngol Relat Spec 1994;56:257-262.
119. +)-ATPase alpha 1 subunit mRNA in the developing rat cochlea. Hear Res 1994;80:31-37.
120. Gratton MA, Smyth BJ, Schulte BA, Vincent DA Jr: Na,K-ATPase activity decreases in the cochlear lateral wall of quiet-aged gerbils. Hear Res 1995;83:43-50.
121. Nakazawa K, Spicer SS, Schulte BA: Ultrastructural localization of Na,K-ATPase in the gerbil cochlea. J Histochem Cytochem 1995; 43:981-991.
122. Vincent DA, Gratton MA, Smyth BJ, Schulte BA: Effect of postmortem autolysis on Na,K-ATPase activity and antigenicity in the gerbil cochlea. Hear Res 1995;89:14-20.
123. Zuo J, Curtis L, Yao X, ten Cate WJ, Rarey K: Expression of Na,K-ATPase alpha and beta isoforms in the neonatal rat cochlea. Acta Otolaryngol (Stockh) 1995;115:497-503.
124. Erichsen S, Zuo J, Curtis L, Rarey K, Hultcrantz M: Na,K-ATPase alpha- and beta-isoforms in the developing cochlea of the mouse. Hear Res 1996;100:143-149.
125. Zuo J, Rarey K: Responsivenenss of alpha 1 and beta 1 cochlear Na,K-ATPase isoforms to thyroid hormone. Acta Otolaryngol (Stockh) 1996;116:422-428.
126. Lippincott L, Rarey KE: Status of cochlear Na,K-ATPase in the aged SHR rat and its possible role in hearing loss. Eur Arch Otorhinolaryngol 1997;254:413-416.
127. Spicer SS, Gratton MA, Schulte BA: Expression pattern of ion transport enzymes in spiral ligament fibrocytes change in relation to striai atrophy in the aged gerbil cochlea. Hear Res 1997;111:93-102.
128. Erichsen S, Stierna B, Bagger-Sjoback D, Curtis LM, Rarey KE, Schmid W, Hultcrantz M: Distribution of Na,K-ATPase is normal in the inner ear of a mouse with a null mutation of the glucocorticoid receptor. Hear Res 1998;124:146-154.
129. Fujimura T, Furukawa H, Doi Y, Fujimoto S: The significance of endothelin for generation of endocochlear potential. J Cardiovasc Pharmacol 1998;31(suppl 1):S376-S377.
130. + recycling pathway from inner hair cells. Hear Res 1998;118:1-12.
131. Wangemann P, Schacht J: Homeostatic mechanisms in the cochlea; in Dallos P, Popper AN, Fay RR (eds): The Cochlea. New York, Springer Handbook of Auditory Research, 1996, vol 8, pp 130-185.
132. Sunose H, Ikeda K, Saito Y, Nishiyama A, Takasaka T: Membrane potential measurement in isolated outer hair cells of the guinea pig cochlea using conventional microelectrodes. Hear Res 1992;62:237-244.
133. +)-ATPase activity in the cochlear lateral wall of the gerbil. Neurosci Lett 1996;213:165-168.
134. Kim HN, Chang MS, Chung MH, Park K: Establishment of primary cell culture from stria vascularis explants: Morphological and functional characterization. Acta Otolaryngol (Stockh) 1996;116:805-811.
135. Kanoh N: Reserpine inhibits the Na,K-ATPase activity of the stria vascularis in the cochlea. Laryngoscope 1994;104:197-200.
136. Kanoh N, Nomura J: The role of L-threo DOPS in the control of Na,K-ATPase activity of the marginal cells in the stria vascularis of reserpinized guinea pigs. Acta Otolaryngol Suppl (Stockh) 1995;520:381-383.
137. Kanoh N: Dopamine inhibits the Na,K-ATPase activity of the stria vascularis in the cochlea. In vivo ultracytochemical study. Acta Otolaryngol (Stockh) 1995;115:27-30.
138. Kanoh N, Ogasawara H, Mohri D, Fukazawa K, Sakagami M: Cytochemical effects of in vitro dopamine treatment on the Na,K-ATPase activity in striai marginal cells. Acta Otolaryngol (Stockh) 1996;116:824-827.
139. +-dependent p-nitrophenylphosphatase activity in striai marginal cells of the cochlea in normal and reserpinized guinea pigs. Acta Otolaryngol (Stockh) 1998;118: 817-820.
140. +-dependent p-nitrophenylphosphatase activity in striai marginal cells of normal and reserpinized guinea pigs. Histochem J 1998;30:263-266.
141. Rarey KE, Tyneway D, Patterson K: Decreased adenosine triphosphatase activity in the absence of adrenocorticosteroids. Arch Otolaryngol Head Neck Surg 1989;115:817-821.
142. Rarey KE, Lohuis PJ, ten Cate WJ: Response of the stria vascularis to corticosteroids. Laryngoscope 1991;101:1081-1084.
143. Lohuis PJ, ten Cate WJ, Patterson KE, Rarey KE: Modulation of the rat stria vascularis in the absence of circulating adrenocorticosteroids. Acta Otolaryngol (Stockh) 1990;110: 348-356.
144. ten Cate WJ, Patterson K, Rarey KE: Ultrastructure of ampullar dark cells in the absence of circulating adrenocorticosteroid hormones. Acta Otolaryngol (Stockh) 1990;110: 234-240.
145. ten Cate WJ, Rarey KE: Plasma membrane modulation of ampullar dark cells by corticosteroids. Arch Otolaryngol Head Neck Surg 1991;117:96-99.
146. Ma YL, Gerhardt KJ, Curtis LM, Rybak LP, Whitworth C, Rarey KE: Combined effects of adrenalectomy and noise exposure on compound action potentials, endocochlear potentials and endolymphatic potassium concentration. Hear Res 1995;91:79-86.
147. Ma YL, Rarey KE, Gerhardt KJ, Curtis LM, Rybak LP: Electrochemical potentials and potassium concentration profiles recorded from perilymph, endolymph and associated inner ear tissues in adrenalectomized rats. Hear Res 1996;96:151-156.
148. Ferrary E, Bernard C, Teixeira M, Julien N, Bismuth P, Sterkers O, Amiel C: Hormonal modulation of inner ear fluids. Acta Otolaryngol (Stockh) 1996;116:244-247.
149. Ma YL, Rarey KE, Gerhardt KJ, Garg LC, Rybak LP: Altered calcium homeostasis in the rat cochlear duct and endogenous corticosteroid insufficiency. Eur Arch Otorhinolaryngol 1997;254:165-168.
150. Spandow O, Anniko M, Hellstrom S: Hydrocortisone applied into the round window niche causes electrophysiological dysfunction of the inner ear. ORL J Otorhinolaryngol Relat Spec 1989;51:94-102.
151. Shirwany NA, Seidman MD, Tang W: Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. Am J Otol 1998; 19:230-235.
152. Lamm K, Arnold W: The effect of prednisolone and non-steroidal anti-inflammatory agents on the normal and noise-damaged guinea pig inner ear. Hear Res 1998;115:149-161.
153. Lamm K, Arnold W: Noise-induced cochlear hypoxia is intensity dependent, correlates with hearing loss and precedes reduction of cochlear blood flow. Audiol Neurootol 1996; 1:148-160.
154. Lamm K, Lamm C, Arnold W: Effect of isobaric oxygen versus hyperbaric oxygen on the normal and noise-damaged hypoxic and ischemic guinea pig inner ear. Adv Otorhinolaryngol 1998;54:59-85.
155. Lamm K, Arnold W: Therapeutic strategies for improving cochlear blood flow; in Prasher D, Canlon B (eds): Cochlear Pharmacology and Noise Trauma. Proceedings of the Joint Symposium organised by the European Commission Concerted Action Protection against Noise The Novartis Foundation. London, Noise Research Network Publications, 1999, pp 150-165.
156. 2 and auditory function in the normal and noise-damaged hypoxic and ischemic guinea pig inner ear. Hear Res, submitted.
157. Park YS, Jung TT, Choi DJ, Rhee CK: Effect of corticosteroid treatment on salicylate ototoxicity. Ann Otol Rhinol Laryrigol 1994;103: 896-900.
158. Nagura M, Iwasaki S, Wu R, Mizuta K, Umemura K, Hoshino T: Effects of corticosteroids, contrast medium and ATP on focal microcirculatory disorders of the cochlea. Eur J Pharmacol 1999;366:47-53.
159. Kusakari C, Hozawa K, Koike S, Kyogoku M, Takasaka T: MRL/MP-1rp/1rp mouse as a model of immune-induced sensorineural hearing loss. Ann Otol Rhinol Laryngol Suppl 1992;157:82-86.
160. Park KY, Hozawa K, Kusakari C, Takasaka T: Effect of steroid administration on immune-mediated sensorineural hearing loss in MRL/MP-1pr/1pr mice. Abstr 4th Int Acad Conf Immunobiol Otol, Rhinol Laryngol, Oita, April 1994, p 124.
161. Henry KR: Noise-induced auditory loss: Influence of genotype, naloxone and methylprednisolone. Acta Otolaryngol (Stockh) 1992;112:599-603.
162. Michel O, Steinmann R, Walger M, Stennert E: Die medikamentöse Beeinflussung der Innenohrfunktion in einem neuen Lärmschädigungsmodell. Otorhinolaryngol Nova 1993;3: 292-297.
163. Takahashi K, Kusakari J, Kimura S, Wada T, Hara A: The effect of methylprednisolone on acoustic trauma. Acta Otolaryngol (Stockh) 1996;116:209-212.
164. d'Aldin C, Cherny L, Dancer A: Medical treatment for acoustic trauma; in Prasher D, Canlon B (eds): Cochlear Pharmacology and Noise Trauma. Proceedings of the Joint Symposium organised by the European Commission Concerted Action Protection Against Noise. The Novartis Foundation. London, Noise Research Network Publications, 1999, pp 54-72.
165. Schneider W, Gjuric M, Katalinic A, Buhr W, Wolf SR: The value of methylprednisolone in the treatment of an experimental sensorineural hearing loss following drill-induced ossicular chain injury: A randomized, blinded study in guinea-pigs. Acta Otolaryngol (Stockh) 1998;118:52-55.
166. McCabe BF: Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979; 88:585-589.
167. Kanzaki J, O-Uchi T: Steroid-responsive bilateral sensorineural hearing loss and immune complexes. Arch Otorhinolaryngol 1981;230:5-9.
168. Kanzaki J, O-Uchi T: Circulating immune complexes in steroid-responsive sensorineural hearing loss and the long-term observation. Acta Otolaryngol Suppl (Stockh) 1983; 393:77-84.
169. Kunihiro T, Kanzaki J, O-Uchi T, Yoshida A: Steroid-responsive sensorineural hearing loss associated with aortitis syndrome. ORL J Otorhinolaryngol Relat Spec 1990;52:86-95.
170. Vischer M, Arnold W: Kortisonsensible Innenohrschwerhörigkeit. Otorhinolaryngol Nova 1991;1:75-79.
171. Kanzaki J, O-Uchi T, Tsuchihashi N: Steroid-responsive sensorineural hearing loss combination therapy with prednisolone and saireito. ORL J Otorhinolaryngol Relat Spec 1993; 55:24-29.
172. Veldman JE, Hanada T, Meeuwsen F: Diagnostic and therapeutic dilemmas in rapidly progressive sensorineural hearing loss. Acta Otolaryngol (Stockh) 1993;113:303-306.
173. Harris JP, Ryan AF: Fundamental immune mechanisms of the brain and inner ear. Otolaryngol Head Neck Surg 1995;112:639-653.
174. Harris JP, Heydt J, Keithley EM, Chen MC: Immunopathology of the inner ear: An update. Ann NY Acad Sci 1997;830:166-178.
175. Barna BP, Hughes GB: Autoimmune inner ear disease - A real entity? Clin Lab Med 1997;17:581-594.
176. Veldman J: Immune-mediated sensorineural hearing loss with or without endolymphatic hydrops: A clinical and experimental approach. Ann NY Acad Sci 1997;830:179-186.
177. Veldman J: Immune-mediated sensorineural hearing loss. Auris Nasus Larynx 1998;25: 309-317.
178. Lamm H: Der Einfluss der hyperbaren Sauerstofftherapie auf den Tinnitus und den Hörverlust bei akuten und chronischen Innenohrschäden. Otorhinolaryngol Nova 1995;5: 161-169.
179. Lamm K: Rationale Grundlagen einer Innenohrtherapie. Otorhinolaryngol Nova 1995;5: 153-160.
180. Lamm K, Lamm H, Arnold W: Effect of hyperbaric oxygen therapy in comparison to conventional or placebo therapy or no treatment in idiopathic sudden hearing loss, acoustic trauma, noise-induced hearing loss and tinnitus. A literature survey. Adv Otorhinolaryngol 1998;54:86-99.
181. Mattox DE, Simmons FB: Natural history of sudden sensorineural hearing loss. Ann Otol 1977;86:463-480.
182. Wilson WR, Byl FM, Laird N: The efficacy of steroids in the treatment of idiopathic sudden hearing loss. Arch Otolaryngol 1980;106: 772-776.
183. Moskowitz D, Lee KJ, Smith HW: Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope 1984;94:664-666.
184. Dornhoffer JL, Arenberg IK: Immune mechanisms in Ménière's syndrome. Otolaryngol Clin North Am 1997;30:1017-1026.
185. Wackym PA, Sando I: Molecular and cellular pathology of Ménière's disease. Otolaryngol Clin North Am 1997;30:947-960.
186. Saeed R: Fortnightly review: Diagnosis and treatment of Ménière's disease. BMJ 1998; 316:368-372.
187. Hamann K, Arnold W: Ménière's disease. Adv Otorhinolaryngol 1999;55:137-168.
188. Sakata E, Kitago Y, Murata Y, Teramoto K: Behandlung der Ménièreschen Erkrankung: Paukenhöhleninfusion von Lidocain-, und Steroidlösung. Auris Nasus Larynx 1986; 13: 79-89.
189. Itoh A, Sakata E: Treatment of vestibular disorders. Acta Otolaryngol Suppl (Stockh) 1991;481:617-623.
190. Shea JJ Jr, Ge X: Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Ménière's disease. Otolaryngol Clin North Am 1996;29:353-358.
191. Shea JJ Jr: The role of dexamethasone or streptomycin perfusion in the treatment of Ménière's disease. Otolaryngol Clin North Am 1997;30:1051-1059.
192. Arriaga MA, Goldman S: Hearing results of intratympanic steroid treatment of endolymphatic hydrops. Laryngoscope 1998;108: 1682-1685.
193. Silverstein H, Isaacson JE, Olds MJ, Rowan PT, Rosenberg S: Dexamethasone inner ear perfusion for the treatment of Ménière's disease: A prospective, randomized, double blind, crossover trial. Am J Otol 1998;19: 196-201.
194. Sakata E, Nakazawa H, Iwashita N: Therapie des Ohrensausens. Paukenhöhleninfusion von Lidocain-, und Steroidlösung. Auris Nasus Larynx 1984;11:11-18.
195. Coles RR, Thompson AC, O'Donoghue GM: Intra-tympanic injections in the treatment of tinnitus. Clin Otolaryngol 1992;17:240-242.
196. Hicks GW: Intratympanic and round-window drug therapy: Effect on cochlear tinnitus. Int Tinnitus J 1998;4:144-147.
197. Lenarz T, Heermann R, Schwab B: Lokaltherapie von Innenohrerkrankungen - Technik und Ergebnisse. Z Audiol 1999;suppl II:28-30.
198. Blakley BW: Clinical forum: A review of intratympanic therapy. Am J Otol 1997;18: 520-531.